2011

April 5th, 2011
,
HLASeq™ Research Screening Panel enables scientists to interrogate entire human leukocyte antigen region and major histocompatibility complex using next-generation sequencing technology
April 5th, 2011
,
..New Multi-center Trial Results Demonstrate Ability of Corus CAD to Identify Obstructive Coronary Artery Disease and Add Independent Information to Coronary Calcium Scoring by CT Angiography April 5th, 2011 • View Comments • Filed Under • by ABMN Staff Filed Under: Business Wire • Press Releases New Multi-center Trial Results Demonstrate Ability of Corus CAD to Identify Obstructive Coronary Artery Disease and Add Independent Information to Coronary Calcium Scoring by CT Angiography
April 4th, 2011
,
Viewable Media is the world's first data-driven video ad network that empowers audiences to choose and share video ads
March 31st, 2011
Navigenics CEO Dr. Vance Vanier named an Aspen Institute Fellow
March 23rd, 2011
,
Leading Silicon Valley Investors Support Innovative Interactive Health Startup
March 22nd, 2011
,
At CTIA Carrier IQ Announces Mobile Intelligence for 4G Devices
March 18th, 2011
,
RainDance Technologies announced the commercial availability of the ASDSeq™ and XSeq™ Research Screening Panels, which enable researchers to simultaneously interrogate key genes known to be linked to X-chromosome disorders and syndromic forms of Autism Spectrum Disorder (ASD)
March 17th, 2011
Discountéo Delivers Compelling Digital Customer Relationship by Integrating VirtuOz Virtual Agent with their Call Center
March 17th, 2011
Tethys Bioscience, Inc. announced that sales of its PreDx® Diabetes Risk Score (DRS) test have exceeded 35,000 units sold since the product was commercially introduced in 2009.